The above findings, combined with the results of the clinical relevance and immune cell infiltration for IL10RA, PRF1, and IL2RA, emphasized that PRF1 and IL2RA might be involved in the mechanism of tumor progress and also provided evidence for the overexpression of the three genes in immune score groups. This evidence concerns the gene IL2RA and neoplasm.